“Prospects of Using the Genetically Engineered Preparation Dupilumab for the Treatment of Atopic Dermatitis in the Adult Population”. 2022. Journal of Pakistan Association of Dermatologists 32 (2): 327-33. https://doi.org/10.66344/jpad.v32i2.1900.